Cambridge Healthtech Institute’s 8th Annual

Cell-Based Immunotherapies

October 4-5, 2021


Efforts to engineer CAR Ts, NKs, TCRs, and TILs with greater precision, safety profiles, and efficacy are leading to the second generation of improved cell therapies. With multiple engineered receptors already making preclinical impact, many biotech and pharma companies are preparing for the next wave of clinical trials. The end goal is still the same: improved patient outcomes.


However, there remain technical considerations and translational challenges relating to cell therapy development, manufacturing practicability, clinical trial approaches, cell quality and persistence, and patient management. Cambridge Healthtech Institute’s 8th Annual Cell-Based Immunotherapies conference focuses on the next steps needed to deliver CAR Ts, NK-CARs, TCRs, and TILs into the clinic.


Coverage will include, but is not limited to:


  • New targeting and engineering strategies
  • Preclinical and clinical updates
  • Progress in solid tumors
  • Overcoming resistance and tumor escape
  • Advances in genetically-modified cell therapies
  • Innate immunity
  • Allogenic cell therapies
  • Combination strategies
  • Advances in NK-CARs
  • Priming the immune system
  • Manipulating the tumor microenvironment


If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is April 9, 2021.


All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:

Daniel Barry

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+44) 7837 651 303



For partnering and sponsorship information, please contact:

Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286


Speaker Proposal